Cargando…

Immunotherapeutic strategies for bladder cancer

Bladder cancer is a common urologic malignancy with rising incidence in the elderly population. In most cases, bladder cancer is non-muscle-invasive at diagnosis and shows dramatically high recurrence rates, although current treatments often reduce the risk of disease progression. Immunotherapy usin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chevalier, Mathieu F, Nardelli-Haefliger, Denise, Domingos-Pereira, Sonia, Jichlinski, Patrice, Derré, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2014
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896526/ https://www.ncbi.nlm.nih.gov/pubmed/24384699 http://dx.doi.org/10.4161/hv.27621

Ejemplares similares

Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer
por: Hojeij, Rim, et al.
Publicado: (2016)

Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies
por: Domingos-Pereira, Sonia, et al.
Publicado: (2022)

Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients
por: Pieraerts, Claire, et al.
Publicado: (2012)

Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8(+) T cells
por: Decrausaz, Loane, et al.
Publicado: (2013)

Targeting endothelial connexin40 inhibits tumor growth by reducing angiogenesis and improving vessel perfusion
por: Alonso, Florian, et al.
Publicado: (2016)

Intravaginal TLR agonists increase local vaccine-specific CD8 T-cells and human papillomavirus-associated genital-tumor regression in mice
por: Domingos-Pereira, Sonia, et al.
Publicado: (2012)

Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments
por: Nguyen, Sylvain, et al.
Publicado: (2022)

Intravesical Ty21a Treatment of Non–muscle-invasive Bladder Cancer Shows a Good Safety Profile
por: Lucca, Ilaria, et al.
Publicado: (2022)

Siglec-7 May Limit Natural Killer Cell–mediated Antitumor responses in Bladder Cancer Patients
por: Benmerzoug, Sulayman, et al.
Publicado: (2021)

Double Positive CD4(+)CD8(+) T Cells Are Enriched in Urological Cancers and Favor T Helper-2 Polarization
por: Bohner, Perrine, et al.
Publicado: (2019)

What is the influence of vaccination’s routes on the regression of tumors located at mucosal sites?
por: Nardelli-Haefliger, Denise, et al.
Publicado: (2012)

Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors
por: Domingos-Pereira, Sonia, et al.
Publicado: (2019)

Targeting Endothelial Connexin37 Reduces Angiogenesis and Decreases Tumor Growth
por: Sathiyanadan, Karthik, et al.
Publicado: (2022)

Vaccination with a nanoparticle E7 vaccine can prevent tumor recurrence following surgery in a human papillomavirus head and neck cancer model
por: Domingos-Pereira, Sonia, et al.
Publicado: (2021)

Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategies
por: Viveiros, Nicole, et al.
Publicado: (2022)

Emerging paradigms in exploring the interactions among diet, probiotics, and cancer immunotherapeutic response
por: Huang, Shi, et al.
Publicado: (2023)

Multifarious immunotherapeutic approaches to cure HIV-1 infection
por: Imami, Nesrina, et al.
Publicado: (2015)

Metastatic primary adenocarcinoma of the bladder in a twenty-five years old woman
por: Valerio, Massimo, et al.
Publicado: (2011)

Proactive Immunotherapeutic Approaches against Inflammatory Breast Cancer May Improve Patient Outcomes
por: Alonso-Miguel, Daniel, et al.
Publicado: (2022)

Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine
por: Engeland, Christine E.
Publicado: (2022)

Advances in immunotherapeutic strategies for colorectal cancer commentary on: tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-CCR5 therapy in cancer patients by Halama et al
por: Deming, Dustin A.
Publicado: (2016)

Refining immunotherapeutic approaches to high‐risk neuroblastoma based on tumor genomic profiles
por: Grossmann, Liron D., et al.
Publicado: (2020)

Novel Immunotherapeutic Strategies of Gastric Cancer Treatment
por: Amedei, Amedeo, et al.
Publicado: (2011)

Immunotherapeutic strategies in autoimmune uveitis
por: Papotto, Pedro Henrique, et al.
Publicado: (2014)

Allergic mechanisms and immunotherapeutic strategies /
Publicado: (1997)

Immunotherapeutic Strategies in the Management of Osteosarcoma
por: Supra, Rajiv, et al.
Publicado: (2023)

Combinatorial immunotherapeutic approaches to restore the function of anergic tumor-reactive cytotoxic CD8(+) T cells
por: Redmond, William L., et al.
Publicado: (2016)

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Liang-Hao, et al.
Publicado: (2021)

Associated pathogenesis of bladder cancer and SARS-CoV-2 infection: a treatment strategy
por: Singh, Mukul Kumar, et al.
Publicado: (2021)

Natural bioactive compounds: a potential therapeutic strategy to sensitize bladder cancer to cisplatin treatment?
por: Ruiz de Porras, Vicenç
Publicado: (2022)

Human γδ T lymphocytes for immunotherapeutic strategies against cancer
por: Kabelitz, Dieter
Publicado: (2010)

Mouse models for pretesting of immunotherapeutic strategies for cancer patients
por: Burchell, JM, et al.
Publicado: (2003)

Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer
por: Martinez, Alejandra, et al.
Publicado: (2020)

Inflammation Control and Immunotherapeutic Strategies in Comprehensive Cancer Treatment
por: Seledtsov, Victor Ivanovich, et al.
Publicado: (2023)

Immunotherapeutic Strategies for Alzheimer's Disease Treatment
por: Solomon, Beka
Publicado: (2009)

Formulation strategies in immunotherapeutic pharmaceutical products
por: Zhang, Yajie, et al.
Publicado: (2020)

Current Immunotherapeutic Strategies for the Treatment of Glioblastoma
por: Dapash, Mark, et al.
Publicado: (2021)

SITC 26(th) annual meeting – summary
por: Romano, Emanuela, et al.
Publicado: (2012)

Targeting Versican as a Potential Immunotherapeutic Strategy in the Treatment of Cancer
por: Hirani, Priyanka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k9jahcaqdsi5nh0skde7pd3ga8